-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On September 13, Zhejiang Longsheng issued an announcement stating that it will jointly establish SPV with Loyal Valley Capital as the main acquisition entity to acquire Hollysys in cash and participate in Hollysys' privatization transaction
According to the announcement, Hollysys was listed on NASDAQ in August 2008 under the stock trading code "HOLI".
According to Hollysys’ publicly disclosed financial statements, Hollysys’ 2020 fiscal year (July 1, 2019 to June 30, 2020) and the first nine months of 2021 fiscal year (July 1, 2020 to 2021) The main financial data as of March 31) are as follows:
Zhejiang Longsheng stated that Hollysys is China's leading automation and information technology solution provider.
It is reported that in addition to Zhejiang Longsheng, Hollysys earlier received a non-binding privatization offer from another company, Superior Emerald (Cayman) Limited (hereinafter referred to as the "Emerald Offer") on July 20, 2021.
It is also understood that earlier on December 7, 2020, Hollysys also announced that it had received a buyer group from Hollysys co-founder and former CEO Shao Baiqing, Ace Lead Profits Limited and CPE Funds Management.
